Back to Search Start Over

Role of compliance in Helicobacter pylorieradication treatment: Results of the European Registry on H. pylorimanagement

Authors :
Huguet, Jose M.
Ferrer‐Barceló, Luis
Suárez, Patrícia
Barcelo‐Cerda, Susana
Sempere, Javier
Saracino, Ilaria Maria
Fiorini, Giulia
Vaira, Dino
Pérez‐Aísa, Ángeles
Jonaitis, Laimas
Tepes, Bojan
Castro‐Fernandez, M.
Pabón‐Carrasco, Manuel
Keco‐Huerga, Alma
Voynovan, Irina
Lucendo, Alfredo J.
Lanas, Ángel
Martínez‐Domínguez, Samuel J.
Alfaro Almajano, Enrique
Rodrigo, Luis
Vologzanina, Ludmila
Bordin, Dmitry S.
Gasbarrini, Antonio
Babayeva, Gülüstan
Lerang, Frode
Leja, Mārcis
Kupčinskas, Juozas
Rokkas, Theodore
Marcos‐Pinto, Ricardo
Meštrović, Antonio
Gridnyev, Oleksiy
Phull, Perminder S.
Smith, Sinead M.
Boltin, Doron
Buzás, György Miklós
Kral, Jan
Şimşek, Halis
Matysiak‐Budnik, Tamara
Milivojevic, Vladimir
Marlicz, Wojciech
Venerito, Marino
Boyanova, Lyudmila
Doulberis, Michael
Capelle, Lisette G.
Cano‐Català, Anna
Moreira, Leticia
Nyssen, Olga P.
Mégraud, Francis
O’Morain, Colm
Gisbert, Javier P.
Source :
United European Gastroenterology Journal; July 2024, Vol. 12 Issue: 6 p691-704, 14p
Publication Year :
2024

Abstract

Adherence to Helicobacter pylori (H. pylori)eradication treatment is a cornerstone for achieving adequate treatment efficacy. To determine which factors influence compliance with treatment. A systematic prospective non‐interventional registry (Hp‐EuReg) of the clinical practice of European gastroenterologists. Compliance was considered adequate if ≥90% drug intake. Data were collected until September 2021 using the AEG‐REDCap e‐CRF and were subjected to quality control. Modified intention‐to‐treat analyses were performed. Multivariate analysis carried out the factors associated with the effectiveness of treatment and compliance. Compliance was inadequate in 646 (1.7%) of 38,698 patients. The non‐compliance rate was higher in patients prescribed longer regimens (10‐, 14‐days) and rescue treatments, patients with uninvestigated dyspepsia/functional dyspepsia, and patients reporting adverse effects. Prevalence of non‐adherence was lower for first‐line treatment than for rescue treatment (1.5% vs. 2.2%; p< 0.001). Differences in non‐adherence in the three most frequent first‐line treatments were shown: 1.1% with proton pump inhibitor + clarithromycin + amoxicillin; 2.3% with proton pump inhibitor clarithromycin amoxicillin metronidazole; and 1.8% with bismuth quadruple therapy. These treatments were significantly more effective in compliant than in non‐compliant patients: 86% versus 44%, 90% versus 71%, and 93% versus 64%, respectively (p< 0.001). In the multivariate analysis, the variable most significantly associated with higher effectiveness was adequate compliance (odds ratio, 6.3 [95%CI, 5.2–7.7]; p< 0.001). Compliance with Helicobacter pylorieradication treatment is very good. Factors associated with poor compliance include uninvestigated/functional dyspepsia, rescue‐treatment, prolonged treatment regimens, the presence of adverse events, and the use of non‐bismuth sequential and concomitant treatment. Adequate treatment compliance was the variable most closely associated with successful eradication.

Details

Language :
English
ISSN :
20506406 and 20506414
Volume :
12
Issue :
6
Database :
Supplemental Index
Journal :
United European Gastroenterology Journal
Publication Type :
Periodical
Accession number :
ejs66921402
Full Text :
https://doi.org/10.1002/ueg2.12569